Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1754studies shown

Showing 1,477-1,488 of 1,754

Behavioral study icon

RecruitingNCT06238700

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 40 Years to 60 Years

Countries: United States
Sponsor: Beth Israel Deaconess Medical Center
Condition: Depression

Behavioral study icon

RecruitingNCT06846320

Adverse Events and Change for anxiety

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AnxietyBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Anxiety

Drug study icon

RecruitingNCT07220460

Adverse Events of Oral ABBV-932 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Bipolarity, Depression

Drug study icon

RecruitingNCT06786624

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Depression

Drug study icon

RecruitingNCT07467993

Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Bulgaria.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria
Sponsor: Novartis Pharmaceuticals
Condition: Schizophrenia

Drug study icon

RecruitingNCT06538558

Use of Tezampanel for Addiction

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Proniras Corporation
Condition: Addiction

Drug study icon

RecruitingNCT07565428

Roluperidone for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Minerva Neurosciences
Condition: Schizophrenia

Drug study icon

RecruitingNCT07363577

LB-102 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: LB Pharmaceuticals Inc.
Condition: Schizophrenia

Drug study icon

RecruitingNCT07680946

Safety study of safety and Efficacy of Ublituximab in schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: TG Therapeutics, Inc.
Condition: Schizophrenia

Drug study icon

RecruitingNCT05303064

Weight Gain for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ...

In United States

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years

Countries: United States, Argentina, Brazil, ...
Sponsor: Alkermes, Inc.
Condition: Bipolarity, Schizophrenia

Drug study icon

RecruitingNCT07639359

Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 99 Years

Countries: United States, Argentina
Sponsor: Hospital Italiano de Buenos Aires
Condition: Depression

Behavioral study icon

RecruitingNCT04459000

Substance Use Treatment and Access to Resources (STARS) Project

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralUp to 55 Years

Countries: United States
Sponsor: University of Oklahoma
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.